Thierry Connerotte

784 total citations
14 papers, 629 citations indexed

About

Thierry Connerotte is a scholar working on Immunology, Genetics and Oncology. According to data from OpenAlex, Thierry Connerotte has authored 14 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Genetics and 5 papers in Oncology. Recurrent topics in Thierry Connerotte's work include Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (7 papers) and vaccines and immunoinformatics approaches (4 papers). Thierry Connerotte is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (7 papers) and vaccines and immunoinformatics approaches (4 papers). Thierry Connerotte collaborates with scholars based in Belgium, France and Switzerland. Thierry Connerotte's co-authors include Pierre G. Coulie, Thierry Boon, Sophie Lucas, Didier Colau, Nicolas van Baren, Aline Van Pel, Vaios Karanikas, Takeshi Hanagiri, Christophe Lonchay and Pierre van der Bruggen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Thierry Connerotte

13 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thierry Connerotte Belgium 11 533 291 224 37 35 14 629
Ashley Knights Australia 13 498 0.9× 322 1.1× 269 1.2× 34 0.9× 21 0.6× 15 705
Robert Sanchez Rodriguez United States 6 379 0.7× 416 1.4× 104 0.5× 33 0.9× 18 0.5× 10 607
Hilde Omholt Norway 6 579 1.1× 384 1.3× 131 0.6× 37 1.0× 44 1.3× 7 689
S. Goldberg United States 11 288 0.5× 182 0.6× 124 0.6× 26 0.7× 63 1.8× 15 439
Fumihiro Fujiki Japan 15 292 0.5× 281 1.0× 320 1.4× 42 1.1× 25 0.7× 42 580
Samuel Alsén Sweden 9 513 1.0× 277 1.0× 191 0.9× 56 1.5× 31 0.9× 15 737
Leticia Barba Switzerland 6 676 1.3× 643 2.2× 150 0.7× 42 1.1× 27 0.8× 6 890
Elien M. Doorduijn Netherlands 10 663 1.2× 496 1.7× 222 1.0× 51 1.4× 31 0.9× 12 867
Sabine Renoth Germany 8 373 0.7× 294 1.0× 122 0.5× 35 0.9× 69 2.0× 11 536
Tania F. Rowley United Kingdom 12 579 1.1× 232 0.8× 123 0.5× 46 1.2× 77 2.2× 13 701

Countries citing papers authored by Thierry Connerotte

Since Specialization
Citations

This map shows the geographic impact of Thierry Connerotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Connerotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Connerotte more than expected).

Fields of papers citing papers by Thierry Connerotte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Connerotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Connerotte. The network helps show where Thierry Connerotte may publish in the future.

Co-authorship network of co-authors of Thierry Connerotte

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Connerotte. A scholar is included among the top collaborators of Thierry Connerotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Connerotte. Thierry Connerotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Knoops, Laurent, Timothy Devos, Yves Béguin, et al.. (2016). The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clinical Biochemistry. 50(7-8). 452–454. 17 indexed citations
2.
Dachy, Guillaume & Thierry Connerotte. (2016). Vanishing bile duct syndrome associated with diffuse large B‐cell lymphoma. British Journal of Haematology. 173(4). 505–505. 1 indexed citations
3.
Ketterer, Nicolas, Catherine Thiéblemont, Christophe Fermé, et al.. (2012). Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B). Annals of Oncology. 24(4). 1032–1037. 21 indexed citations
4.
Sinapi, Isabelle, et al.. (2010). Fibrose rétropéritonéale et myélome multiple : association fortuite ?. La Revue de Médecine Interne. 31(5). e4–e6.
5.
Stockis, Julie, Violaine François, Thierry Connerotte, et al.. (2009). Comparison of stable human Treg and Th clones by transcriptional profiling. European Journal of Immunology. 39(3). 869–882. 59 indexed citations
6.
Knoops, Laurent, Thierry Connerotte, Caroline Smal, et al.. (2009). Impaired up‐regulation of polo‐like kinase 2 in B‐cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2‐chlorodeoxyadenosine: a potential marker of defective damage response. British Journal of Haematology. 147(5). 641–652. 12 indexed citations
8.
Connerotte, Thierry, Aline Van Pel, Danièle Godelaine, et al.. (2008). Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities. Cancer Research. 68(10). 3931–3940. 48 indexed citations
9.
Coulie, Pierre G. & Thierry Connerotte. (2005). Human tumor-specific T lymphocytes: does function matter more than number?. Current Opinion in Immunology. 17(3). 320–325. 40 indexed citations
10.
Lonchay, Christophe, Pierre van der Bruggen, Thierry Connerotte, et al.. (2004). Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen. Proceedings of the National Academy of Sciences. 101(suppl_2). 14631–14638. 121 indexed citations
11.
Karanikas, Vaios, Christophe Lurquin, Didier Colau, et al.. (2003). Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus. The Journal of Immunology. 171(9). 4898–4904. 88 indexed citations
12.
Dietrich, Pierre-Yves, Frédérique‐Anne Le Gal, Valérie Dutoit, et al.. (2003). Prevalent Role of TCR α-Chain in the Selection of the Preimmune Repertoire Specific for a Human Tumor-Associated Self-Antigen. The Journal of Immunology. 170(10). 5103–5109. 65 indexed citations
13.
Coulie, Pierre G., Vaios Karanikas, Christophe Lurquin, et al.. (2002). Cytolytic T‐cell responses of cancer patients vaccinated with a MAGE antigen. Immunological Reviews. 188(1). 33–42. 101 indexed citations
14.
Trautmann, Lydie, Nathalie Labarrière, Francine Jotereau, et al.. (2002). Dominant TCR Vα  usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens. European Journal of Immunology. 32(11). 3181–3190. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026